Publication
Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia.
Authors not recorded
Int J Lab Hematol2021PMID 33988307PMC7611455stubpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CIVIC-20260908-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Data not yet available
No abstract stored. Read on PubMed
Linked entities
Linked entities (2)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 2
- geneZNF384civic_curation1.00
- variantZNF384 Fusioncivic_curation1.00
Curated evidence
Evidence citing this paper (1)
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 33988307
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| ZNF384 Fusion1 | ||||||||
| (diagnostic) | B-lymphoblastic Leukaemia/lymphoma With Other Defined Genetic AlterationsUNRESOLVED | Diagnostic | B | Supports Positive | 3 | accepted | EID12442In this study, the authors investigated a targeted diagnostic approach to identify ZNF384 rearrangements in B-lymphoblastic leukemia/lymphoma (B-ALL) based on immunophenotypic features. Since ZNF384 … (full text at CIViC) PMID 33988307 · Janet et al., 2021 · Open in CIViC | civic |